355 related articles for article (PubMed ID: 35445729)
1. Curcumin and Wnt/β‑catenin signaling in exudative age‑related macular degeneration (Review).
Vallée A
Int J Mol Med; 2022 Jun; 49(6):. PubMed ID: 35445729
[TBL] [Abstract][Full Text] [Related]
2. PPARγ agonists: Potential treatments for exudative age-related macular degeneration.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Life Sci; 2017 Nov; 188():123-130. PubMed ID: 28887057
[TBL] [Abstract][Full Text] [Related]
3. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
4. Circadian Rhythms in Exudative Age-Related Macular Degeneration: The Key Role of the Canonical WNT/β-Catenin Pathway.
Vallée A; Lecarpentier Y; Vallée R; Guillevin R; Vallée JN
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012797
[TBL] [Abstract][Full Text] [Related]
5. Aerobic Glycolysis Hypothesis Through WNT/Beta-Catenin Pathway in Exudative Age-Related Macular Degeneration.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
J Mol Neurosci; 2017 Aug; 62(3-4):368-379. PubMed ID: 28689265
[TBL] [Abstract][Full Text] [Related]
6. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
Eyetech Study Group
Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
[TBL] [Abstract][Full Text] [Related]
7. JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration.
Du H; Sun X; Guma M; Luo J; Ouyang H; Zhang X; Zeng J; Quach J; Nguyen DH; Shaw PX; Karin M; Zhang K
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2377-82. PubMed ID: 23341606
[TBL] [Abstract][Full Text] [Related]
8. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.
Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM
Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075
[TBL] [Abstract][Full Text] [Related]
9. Subthreshold Exudative Choroidal Neovascularization (CNV): Presentation of This Uncommon Subtype and Other CNVs in Age-Related Macular Degeneration (AMD).
Douglas VP; Garg I; Douglas KAA; Miller JB
J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456174
[TBL] [Abstract][Full Text] [Related]
10. [Age-related Macular Degeneration in the Japanese].
Yoshimura N
Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia.
Hashemi S; Faramarzi MA; Ghasemi Falavarjani K; Abdollahi M
Expert Opin Biol Ther; 2014 Dec; 14(12):1837-48. PubMed ID: 25283631
[TBL] [Abstract][Full Text] [Related]
12. Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy.
Kokame GT; deCarlo TE; Kaneko KN; Omizo JN; Lian R
Ophthalmol Retina; 2019 Sep; 3(9):744-752. PubMed ID: 31511169
[TBL] [Abstract][Full Text] [Related]
13. [Morphology of outer retinal tubulations in the outcome of exudative age-related macular degeneration according to optical coherence tomography angiography].
Kurysheva NI; Pererva OA; Ivanova AA
Vestn Oftalmol; 2021; 137(4):72-80. PubMed ID: 34410060
[TBL] [Abstract][Full Text] [Related]
14. WNT7A/B promote choroidal neovascularization.
Lin JB; Sene A; Wiley LA; Santeford A; Nudleman E; Nakamura R; Lin JB; Moolani HV; Apte RS
Exp Eye Res; 2018 Sep; 174():107-112. PubMed ID: 29864439
[TBL] [Abstract][Full Text] [Related]
15. An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
Feng L; Hu JH; Chen J; Xie X
J Zhejiang Univ Sci B; 2018 Apr.; 19(4):327-332. PubMed ID: 29616508
[TBL] [Abstract][Full Text] [Related]
16. [Anti-VEGF therapy resistance in neovascular age-related macular degeneration].
Budzinskaya MV; Plyukhova AA; Sorokin PA
Vestn Oftalmol; 2017; 133(4):103-108. PubMed ID: 28980574
[TBL] [Abstract][Full Text] [Related]
17. SPAG5, the upstream protein of Wnt and the target of curcumin, inhibits hepatocellular carcinoma.
Li H; Qin Y; Huang Y; Wang J; Ren B
Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37539742
[TBL] [Abstract][Full Text] [Related]
18. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
Tamaki Y
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
[TBL] [Abstract][Full Text] [Related]
19. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
Kokame GT; Omizo JN; Kokame KA; Yamane ML
Ophthalmol Retina; 2021 Oct; 5(10):954-961. PubMed ID: 34022443
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
Noël A; Jost M; Lambert V; Lecomte J; Rakic JM
Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
